Lupoid sclerosis

Rheumatology International

Volumn 30, Issue 4, 2010, Pages 431-434

  Keiserman, Briele ^a   Da Silva, Luiz Fernando Garcias ^a   Keiserman, Mauro W ^a   Von Mühlen, Carlos Alberto ^a   Staub, Henrique Luiz ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antiphospholipid antibodies; Lupoid sclerosis; Multiple sclerosis; Systemic lupus erythematosus

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY; RITUXIMAB; SM ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG RESPONSE; HUMAN; IMMUNOADSORPTION; LABORATORY DIAGNOSIS; LUPOID SCLEROSIS; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; BLOOD; IMMUNOLOGY; MEDLINE; PATHOLOGY;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MULTIPLE SCLEROSIS; PUBMED;

EID: 77949880179     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1175-1     Document Type: Review

References (60)

1. Feletar M, Ibanez D, Urowitz MG, Gladman DD (2003) The impact of the 1997 update of the American College of Rheumatology revised criteria for the classiWcation of systemic lupus erythematosus: what has been changed? Arthritis Rheum 48(7):2067-2069 (Pubitemid 36828703)
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al (2006) International consensus statement on an update of the classiWcation criteria for deWnite antiphospholipid syndrome (APS). J Thromb Haemost 4:295-306
3. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "MacDonald Criteria". Ann Neurol 58:840-846 (Pubitemid 41746873)
4. Levine SR, Welch KM (1987) The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulant and anticardiolipin antibodies. Arch Neurol 44:876-883
5. Theodoridou A, Settas L (2006) Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 77(3):290-295 (Pubitemid 43295146)
6. Shepherd DI, Downie AW, Best PV (1974) Systemic lupus erythematosis and multiple sclerosis. Trans Am Neurol Assoc 99:173-176
7. Stepien M, Cendrowski W (1974) Form of systemic lupus erythematosus (lupoid sclerosis) resembling multiple sclerosis. Neurol Neurochir Pol 8:607-609
8. Kaplan PE, Betts HB (1977) Lupoid sclerosis: evaluation and treatment. Arch Phys Med Rehabil 58:24-28 (Pubitemid 8025198)
9. Ellenberg M (1978) Lupoid sclerosis. Arch Phys Med Rehabil 59:43-44
10. Knapik-Kordecka M, Plamieniak Z (1980) Case of visceral lupus erythematosus coexisting with multiple sclerosis. Pol Tyg Lek 35(28):1075-1076
11. Rosati G, Serra G, Trotta F, Tralli G, Artioli M (1981) Systemic lupus erythematosus and multiple sclerosis. Riv Neurobiol 27(1):158-164 (Pubitemid 12035713)
12. Hutchinson M, Bresnihan B (1983) Neurological lupus erythematosus with tonic seizures simulating multiple sclerosis. J Neurol Neurosurg Psychiatry 46(6):583-585 (Pubitemid 13099714)
13. Hoppe B, Zajaczek-Grabowska A (1984) Diagnostic diYculties in a case of visceral lupus with disseminated neurological signs. Neurol Neurochir Pol 18:489-491
14. Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, Derue G, Hughes GRV (1985) Lupoid sclerosis: a possible role for antiphospholipid antibodies. Ann Rheum Dis 44:281-283 (Pubitemid 15112846)
15. Lorcerie B, Marchal G, Borsotti JP, Guard O, Giroud M, Dumas R et al (1989) Multiple sclerosis associated with biological symptoms of systemic lupus erythematosus. A case with anatomical study. Rev Med Interne 10:471-474 (Pubitemid 19268897)
16. Moriwaka F, Tashiro K, Fukazawa T, Akino M, Yasuda I, Sagawa A, Hida K (1990) A case of systemic lupus erythematosus: its clinical and MRI resemblance to multiple sclerosis. Jpn J Psychiatry Neurol 44(3):601-605
17. van der Kaaden AJ, Kamphuis DJ, Nossent JC, Rico RE (1993) Longstanding isolated cerebral systemic lupus erythematosus in an 8-year-old black girl. Resemblance with multiple sclerosis. Clin Neurol Neurosurg 95(3):241-244
18. Kinnunen E, Müllher K, Keto P, Ketonen L, Helve T, Sepponen R (1993) Cerebrospinal Xuid and MRI Wndings in three patients with multiple sclerosis and systemic lupus erythematosus. Acta Neurol Scand 87:356-360 (Pubitemid 23171048)
19. Dabadghao S, Aggarwal A, Misra R (1995) Lupoid sclerosis with raised anticardiolipin antibodies. J Assoc Physicians India 43:298
20. Banerjee S, Kumar L, Singh S, Kakkar N (1997) Multiple sclerosis and systemic lupus erythematosus in a 10-year-old girl. Indian Pediatr 34(2):159-162 (Pubitemid 127512572)
21. Schantz V, Oestergaard LL, Junker P (1998) Shrinking spinal cord following transverse myelopathy in a patient with systemic lupus erythematosus and the phospholipid antibody syndrome. J Rheumatol 25(7):1425-1428 (Pubitemid 28312365)
22. Carter D, Olchovski D, Yonath H, Langevitz P, Ezra D (2006) Simultaneous deep vein thrombosis and transverse myelitis with negative sorology as a Wrst sign of antiphospholipid syndrome: a case report and review of the literature. Clin Rheumatol 25:756-758 (Pubitemid 44111326)
23. Lima I, Melo A, Brandi IV, Costa O, Santiago M (2007) Lupoid sclerosis: what is the role of antiphospholipid antibodies? J Clin Rheumatol 13:85-86 (Pubitemid 46597672)
24. Kasitanon N, Louthrenoo W, Piyasirisilp S, Sukitawu W, Wichainun R (2002) Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 20(3):179-185 (Pubitemid 36253669)
25. Kovacs B, LaVerty TL, Brent LH, DeHoratius RJ (2000) Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis 59(2):120-124 (Pubitemid 30305609)
26. Mok CC, Lau CS, Chan EY, Wong RW (1998) Acute transverse myelopathy in systemic lupus erythematosus: clinical presentation, treatment, and outcome. J Rheumatol 25(3):467-473
27. Inslicht DV, Stein AB, Pomerantz F, Ragnarsson KT (1998) Three women with lupus transverse myelitis: case reports and diVerential diagnosis. Arch Phys Med Rehabil 79(4):456-459 (Pubitemid 28204628)
28. Zenone T, Steineur MP, Sibille M, Durieu I, Vital Durand D (2000) Myelopathy revealing lupus. Two cases and review of the literature. Rev Med Interne 21:1114-1120
29. D'Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J et al (2004) Transverse myelitis as the Wrst manifestation of systemic lupus erythematosus and lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. Rheumatology 31:280-285 (Pubitemid 38160749)
30. Téllez-Zenteno JF, Remes-Troche JM, Negrete-Pulido RO, Dávila Maldonado L (2001) Longitudinal myelitis associated with systemic lupus erythematosus: clinical features and magnetic resonance imaging of six cases. Lupus 10:851-856
31. Lehnhard FR, Impekoven P, Rubbert A, Burghaus L, Nevelin M, Heiss WD, Jacobs AH (2004) Recurrrent longitudinal myelitis as primary manifestation of SLE. Neurology 63(10):1976
32. Heinlein AC, Gertner E (2007) Marked inXammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus 16(10):823-826 (Pubitemid 350069796)
33. Kim JH, Lee SI, Park SI, Yoo WH (2004) Recurrent transverse myelitis in primary antiphospholipid syndrome-case report and literature review. Rheumatol Int 24:244-246 (Pubitemid 39062499)
34. Takamura Y, Morimoto S, Tanooka A, Yoshikawa J (1996) Transverse myelitis in a patient with primary antiphospholipid syndrome. A case report. No To Shinkei 48:851-855 (Pubitemid 26327846)
35. Shaharao V, Bartakke S, Muranjan MN, Bavdekar MS, Bavdekar SB, Udani VP (2004) Recurrent acute transverse myelopathy: association with antiphospholipid antibody syndrome. Indian J Pediatr 71:559-561 (Pubitemid 38917403)
36. Chapman J (2004) The interface of multiple sclerosis and antiphospholipid antibodies. Thromb Res 114:477-481 (Pubitemid 39422581)
37. Ferreira S, D'Cruz DP, Hughes GR (2005) Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 44:434-442 (Pubitemid 41511130)
38. Suárez Alvarez L, Hughes GR, Khamashta MA (2005) Neurological manifestations of the antiphospholipid syndrome. Med Clin (Barc) 124:630-633 (Pubitemid 40780795)
39. Ijdo JW, Conti-Kelly AM, Greco P, Abedi M, Amos Provenzale JM et al (1999) Antiphospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus 8:109-115 (Pubitemid 29103596)
40. Cuadrado MJ, Khamastha MA, Ballesterol A, Godfrey T, Simon MF, Hughes GR (2000) Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature. Medicine (Baltimore) 79:57-68 (Pubitemid 30077737)
41. Marullo S, Clauvel JP, Intrator L, Danon F, Brouet JC, Oksenhendler E (1993) Lupoid sclerosis with antiphospholipid and antimyelin antibodies. J Rheumatol 20:747-749 (Pubitemid 23138873)
42. Inoue Y, Yoshino H (1998) Acute transverse myelitis presenting with syrinx formation associated with anti-sulfated glucuronyl lactosaminyl paragloboside antibody and anticardiolipin antibodies. No To Shinkei 50:181-185 (Pubitemid 28136362)
43. Wingerchuck DM, Hogancamp WF, O'Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 53:1107-1114
44. Ghezzi A, Bergamaschi R, Martinelli V, Trojano M, Tola MR, Merelli E et al (2004) Italian Devic's Study Group (IDESG). Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 251:47-52
45. Scott TF, Kassab SL, Pittock SJ (2006) Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol 63:1398-1400
46. Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B (2008) Vanderbilt. Mechanisms of Disease: aquaporin-4 antibodies in neuromyelitis optica. Nat Clin Pract Neurol 4(4):202-214 (Pubitemid 351516748)
47. April RS, Vansonnenberg E (1976) A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus. Clinicopathologic report an review of the literature. Neurology 26:1066-1070
48. Jacobi C, Stingele K, Kretz R, Hartmann M, Storch-Hagenlocher B, Breitbart A et al (2006) Neuromyelitis optica (Devic's syndrome) as Wrst manifestation of systemic lupus erythematosus. Lupus 15:107-109 (Pubitemid 43345337)
49. Ferreira S, Marques P, Carneiro E, D'Cruz D, Gama G (2005) Devic's syndrome in systemic lupus erythematosus and probable antiphospholipid syndrome. Rheumatology (Oxford) 44:693-695 (Pubitemid 41487251)
50. de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier- Vehier F et al (2002) Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome proWle. J Neurol Sci 197:57-61
51. Govoni M, Padovan M, Rizzo N, Trotta F (2001) CNS involvement in primary Sjogren's syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs 15:597-607
52. Mellgren SI, Göransson LG, Omdal R (2007) Primary Sjögren's syndrome associated neuropathy. 1. Can J Neurol Sci 34(3):280-287
53. Yamamoto T, Ito S, Hattori T (2006) Neurological picture. Acute longitudinal myelitis as the initial manifestation of Sjögren's syndrome. J Neurol Neurosurg Psychiatry 77(6):780
54. Neuwelt CM, Lacks S, Kaye BR, Ellman JB, Borenstein DG (1995) Role of intravenous cyclophosphamide in the treatment of severe neuropsychiatric systemic lupus erythematosus. Am J Med 98(1):32-41
55. Fukui W, Sano H, Tanabe T, Ueda T, Hirohata S, Hashiramoto A, Yamada R, Kato H, Kondo M (1998) A case of severe neuropsychiatric lupus erythematosus treated by plasmapheresis: diagnostic values of serum antiribosomal P protein antibodies and interleukin- 6 in cerebrospinal Xuid. Nihon Rinsho Meneki Gakkai Kaishi 21(4):172-179
56. Taniguchi Y, Yorioka N, Okushin S, Oda H, Usui K, Yamakido M (1995) Usefulness of immunoadsorption therapy for systemic lupus erythematosus associated with transverse myelitis. A case report. Int J Artif Organs 18(12):799-801
57. Armstrong DJ, McCarron MT, Wright GD (2006) SLE-associated transverse myelitis successfully treated with Rituximab (anti- CD20 monoclonal antibody). Rheumatol Int 26(8):771-772
58. Lehnhardt FG, Scheid C, Holtik U, Burghaus L, Neveling M, Impekoven P, Rüger A, Hallek M, Jacobs AH, Rubbert A (2006) Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction. Lupus 15(4):240-243
59. Yamawaki T, Suzuki N (1997) Can immunoadsorption plasmapheresis be used as the Wrst choice therapy for neuroimmunological disorders? Ther Apher 1(4):348-352
60. Keiserman B, Garcias da Silva LF, Keiserman MW, von Mühlen CA, Staub HL (2008) Polemics on lupoid sclerosis. Rev Bras Rheumatol 48(1):62-65